Live SpaceX Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Incannex Healthcare Inc.

Get SEC filing alerts via email and in your feed for Incannex Healthcare Inc.

IXHL

Incannex Healthcare Inc.

About Incannex Healthcare Inc.

Incannex Healthcare Inc. is a clinical-stage biopharmaceutical company developing innovative medicines for serious chronic diseases with unmet needs. Its lead programs include treatments for obstructive sleep apnea, generalized anxiety disorder, and inflammatory conditions like rheumatoid arthritis. The company focuses on evidence-based, combination therapies, leveraging regulatory pathways such as FDA expedited review, and maintains a strong intellectual property portfolio to maximize global market potential.
This description was generated via AI from an annual report. Updated 9 months ago.

Latest SEC Filings from Incannex Healthcare Inc.

1
1
Incannex Healthcare Inc. Incannex Healthcare Reports Decrease in Operating Losses and Increase in Cash Reserves

Via official filing (AI summary) | about 1 month ago | 0 comments

2
1
Incannex Healthcare Inc. Incannex Healthcare Reports Increased Cash Reserves but Continued Operational Losses in Q2 FY2026

Via official filing (AI summary) | 4 months ago | 0 comments

3
1
Incannex Healthcare Inc. Incannex Healthcare Reports $6.4 Million Net Loss and No Revenue for Quarter Ending September 30, 2025

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
Incannex Healthcare Inc. Incannex Healthcare Reports $46.9 Million Net Loss and Significant Revenue Growth in Fiscal Year 2025

Via official filing (AI summary) | 9 months ago | 0 comments

5
1
Incannex Healthcare Inc. Incannex Healthcare Reports $3.97 Million Net Loss for Quarter, Decreases Operating Expenses

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
Incannex Healthcare Inc. Incannex Healthcare Reports $5.9 Million Net Loss in Q2 Fiscal 2025

Via official filing (AI summary) | over 1 year ago | 0 comments

7
1
Incannex Healthcare Inc. Incannex Healthcare Reports Significant Revenue Challenges, Increased Operating Losses in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments